Prosecution Insights
Last updated: October 25, 2026
Application No. 18/658,193

ORGANIC COMPOUND AND ELECTROLUMINESCENT DEVICE

Non-Final OA §102§103
Filed
May 08, 2024
Priority
Nov 09, 2021 — CN 202111320218.1 +2 more
Examiner
RHOADES, DEREK JAMES
Art Unit
1692
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Sichuan Ag-Ray New Materials Co. Ltd.
OA Round
1 (Non-Final)
72%
Grant Probability
Favorable
1-2
OA Rounds
1y 1m
Est. Remaining
89%
With Interview

Examiner Intelligence

Grants 72% — above average
72%
Career Allowance Rate
60 granted / 83 resolved
+12.3% vs TC avg
Strong +16% interview lift
Without
With
+16.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
32 currently pending
Career history
112
Total Applications
across all art units

Statute-Specific Performance

§101
0.5%
-39.5% vs TC avg
§103
42.9%
+2.9% vs TC avg
§102
14.9%
-25.1% vs TC avg
§112
24.1%
-15.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 83 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Status Claims 1-20 are pending. No claims have been amended. No claims have been canceled. Thus, claims 1-20 represent all claims currently under consideration. Priority Domestic Priority data as claimed by Applicant: This application is a CON of PCT/CN2022/123697 (10/04/2022) Foreign Applications: CHINA 202111320218.1 (11/09/2021) CHINA 202211173070.8 (09/26/2022) Receipt is acknowledged of certified copies of papers required by 37 CFR 1.55. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-10 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Huang et al. (CN110734388A; published 01-31-2020; IDS of 05-15-2024; Original Document and English language machine translation obtained from Espacenet on 10-06-2026). Regarding claim 1, Huang discloses hole injection compounds and applications thereof including organic electroluminescent devices such as OLEDs. Of particular note, Huang discloses a preferred hole injection compound of the following structure: PNG media_image1.png 208 221 media_image1.png Greyscale This compound anticipates the genus of formula (1) of claim 1, the genus of claim 2, and the genus of formula (2) of claim 3 when Z is a single bond, X1-X6 are CN, and Z1-Z3 are O. Further regarding claims 1-3 and claims 4-10, Huang discloses a preferred hole injection compound of the following structure (Title; Abstract; 0026; Original Document as filed in IDS; 0028, 0070, and 0079; claims 1 and 9-10; English language machine translation): PNG media_image2.png 334 375 media_image2.png Greyscale This compound anticipates the genus of formula (1) of claim 1, the genus of claim 2, and the genus of formula (2) of claim 3 when Z is a single bond, X1-X6 are CN, and Z1-Z3 are CR2R3, wherein R2 is CN and R3 is substituted C6 aryl. Furthermore, this compound also anticipates the genus of claims 4-10 because all of Z1-Z3 are CR2R3, both R2 and R3 are electron-withdrawing groups, R2-R3 are independently selected from CN and substituted C6 aryl wherein the substituents are F and CN (i.e., a C6-aryl containing groups with electron-withdrawing properties as recited in claim 9), and X1-X6 are CN. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claims 1-20 are rejected under 35 U.S.C. 103 as being unpatentable over Huang et al. (CN110734388A; published 01-31-2020; IDS of 05-15-2024; Original Document and English language machine translation obtained from Espacenet on 10-06-2026), as evidenced by Shahnawaz et al. (“Hole-transporting materials for organic light-emitting diodes: an overview”; J. Mater. Chem. C. 2019, 7, 7144-7158; published 05-16-2019). Regarding claims 1-10, the teachings of Huang are incorporated herein as detailed in the rejections above. Regarding claim 11, Huang does not explicitly teach the organic compound according to claim 1, which has one of the structures of species CPD 001-CPD 098, as recited in the instant claim. However, Huang teaches a genus of hole injection compound for use in hole transport materials as shown in Formula I: PNG media_image3.png 233 249 media_image3.png Greyscale wherein X1-X6 are each independently any of of CX7, B or N, X7 is any group that satisfies its chemical environment, R1, R2, and R3 are each independently any one of O, S, =N(CN), =CR4R5 or substituted or unsubstituted quinones, R4 and R5 are each independently any group that satisfies its chemical environment, and n is an integer from 0 to 5. Huang further teaches a preferred restricted genus of Formula I wherein X7 is any one of cyano, halogen, substituted or unsubstituted alkyl, substituted or unsubstituted alkynyl, acyl, aldehyde, carboxyl, ester, mercapto, thionyl, sulfonyl, phosphinyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or substituted or unsubstituted quinone; and wherein R4 and R5 are each independently any one of substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, cyano, halogen (any one of fluorine, chlorine, bromine or iodine), substituted or unsubstituted alkynyl, acyl, aldehyde, carboxyl, ester, mercapto, thionyl, sulfonyl, or phosphine (Formula I in 0008 and claim 1; Original Document; 0014-0015 and 0018; claims 1-2, 4, and 7; English language machine translation). Huang also teaches a subgenus of preferred species as hole injection compounds, including the following species that reside within the genus of claims 1-10, as detailed in the rejections above: PNG media_image2.png 334 375 media_image2.png Greyscale Furthermore, Huang teaches a structurally similar preferred species which depicts a terminal =(CN)2 group as a preferred substituent that corresponds to R2 = R3 = CN in formula (1) of claim 1 on which the instant claim depends (emphasis added; 0026 of Original Document): PNG media_image4.png 279 314 media_image4.png Greyscale Therefore, since the genus and a preferred species of Huang teach compounds depicting a terminal =(CN)2 group as a preferred substituent, the skilled artisan could arrive at the following species CPD 031 as recited in claim 11 with a reasonable expectation of success based on the teachings of Huang alone: PNG media_image5.png 202 208 media_image5.png Greyscale In addition, the skilled artisan could arrive at the species CPD 046 as recited in claim 11 with a reasonable expectation of success by replacing the CN groups of the known species of Huang detailed above with F, because the broader genus of Huang teaches that both CN and F are suitable substituents for compounds corresponding to X1-X6 of formula (1) of claim 1 on which the instant claim depends: PNG media_image6.png 241 209 media_image6.png Greyscale The prior art as taught by Huang is analogous to the claimed invention because Huang teaches compounds for electroluminescent devices, including species that reside within formula (1) of instant claim 1 and a broader genus that encompasses the aforementioned species of instant claim 11, and a subgenus of preferred species that are structurally similar to the aforementioned species of instant claim 11. As such, the skilled artisan would have been sufficiently motivated to pursue the known compounds described by the genus of Huang that broadly overlaps with the instantly claimed genus to arrive at compounds CPD 031 and CPD 046 as described in instant claim 11 with a reasonable expectation of success. Furthermore, since Huang teaches a genus and preferred species which have significant structural similarity with the instantly claimed species, and falls within the scope of organic compounds and use thereof in an organic electroluminescent device, the skilled artisan could reasonably predict that all of the compounds possess the same utility. MPEP § 2144.08(II)(A)(4)(c) states that “The closer the physical and/or chemical similarities between the claimed species or subgenus and any exemplary species or subgenus disclosed in the prior art, the greater the expectation that the claimed subject matter will function in an equivalent manner to the genus. See, e.g., Dillon, 919 F.2d at 696, 16 USPQ2d at 1904 (and cases cited therein).” Therefore, it would have been prima facie obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have arrived at the claimed species as recited in claim 11 based on the teachings of Huang. Regarding claims 12-14 and 16-20, Huang teaches an electroluminescent device OLED device which comprises, from bottom to top, an anode, a hole injection layer, a hole transport layer, a light-emitting layer, an electron transport layer, and a cathode. The hole injection compounds disclosed by Huang are highly suitable for use as a hole injection material in OLED devices and has excellent hole injection performance. Organic light-emitting elements doped with the compounds of Huang in the hole transport layer effectively improve device lifespan. An objective of the invention of Huang is to provide a hold transport material, wherein the hole transport material is doped with the hole injection compound provided by the invention of Huang. The skilled artisan would recognize that the hole injection layer of Huang comprises the organic compounds and is arranged between the cathode and anode, in a manner consistent with the limitations of claims 12-13 and 16-20. Further regarding claim 14, the material selections for the hole injection layer and the hole transport layer are shown in Table 1. Examples 1-4 of Huang show mixtures of compounds of the present invention (i.e., HI1-HI4) with NPB, a triarylamine with the following chemical structure (0068-0070 and Table 1; Original Document; 0008, 0030-0031, 0033, 0070, 0079; claims 9-10; Examples 1-4; English language machine translation): PNG media_image7.png 141 266 media_image7.png Greyscale Although Examples 1-4 of Huang do not explicitly teach the use of compounds according to instant claims 1-5 and 11, the teachings of Huang render the limitations of these claims obvious as detailed above, and Huang further teachings that the embodiments described are merely illustrative of the invention and should not be construed as limiting the invention (0035; English language machine translation). Therefore, the skilled artisan could predictably arrive at an electroluminescent device wherein the hole injection layer comprises an organic compound of claims 1-5 and/or 11 and a hole transport material containing a triarylmine (i.e., NPB) with a reasonable expectation of success to arrive at the limitations of claims 12-14 and 16-20 based on the teachings of Huang alone. Regarding claim 15, although Huang teaches the use of the triarylamine NPB as a hole transport material (0068-0070 and Table 1; Original Document; 0070 and Examples 1-4; English language machine translation), Huang does not explicitly teach wherein an absolute value of a highest occupied molecular orbital energy level HOMO of the hole transport material containing triarylamine or carbazole is 4.8-6.8 eV, as recited in claim 15. However, 4,4’-Bis[N-(1-napthyl)-N-phenylamino]biphenyl (NPB) is considered one of the most successful hole transport materials and is largely used in organic devices owing to its good carrier mobility, high transparency for visible light and well-matched HOMO level (5.4 eV) for hole injection and hole transport, as evidenced by Shahnawaz (page 7144, Col. 2, paragraph 1). The 5.4 eV HOMO level of NPB resides within the range recited in the instant claim. MPEP § 2144.05(I) states that “[i]n the case where the claimed ranges ‘overlap or lie inside ranges disclosed by the prior art’ a prima facie case of obviousness exists.” Therefore, the skilled artisan would predictably arrive at the limitation of claim 15 based on the teachings of Huang in view of the evidentiary teachings of Shahnawaz. Based on the combined teachings of the references, the Examiner submits that a person of ordinary skill in the art would have had a reasonable expectation of success of arriving at the instantly claimed compounds and electroluminescent devices comprising said compounds. Therefore, the invention as a whole would have been prima facie obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, and absent a clear showing of evidence to the contrary. Conclusion Any inquiry concerning this communication or earlier communications from the Examiner should be directed to Derek Rhoades whose telephone number is (703)-756-5321. The Examiner can normally be reached Monday–Thursday, 7:30 am–5:00 pm EST; Friday, 7:30 am–4:00 pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the Examiner’s supervisor, Scarlett Goon can be reached on 571-270-5241. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /D.R./Examiner, Art Unit 1692 /AMY C BONAPARTE/Primary Examiner, Art Unit 1692
Read full office action

Prosecution Timeline

May 08, 2024
Application Filed
Oct 13, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12767673
MONOMER COMPOSITION PRODUCTION METHOD AND MONOMER COMPOSITION
3y 3m to grant Granted Oct 20, 2026
Patent 12767676
METHOD FOR PRODUCING DIPHOSPHINE MONOXIDE
2y 12m to grant Granted Oct 20, 2026
Patent 12752262
METHOD OF PRODUCING NANOSTRUCTURED IRON-BASED CATALYSTS FOR CONVERTING SYNGAS TO LIGHT OLEFINS
4y 4m to grant Granted Oct 06, 2026
Patent 12746237
CRYSTALLIZATION PROCESS OF ARIPIPRAZOLE DERIVATIVES IN EXTENDED RELEASE FORMULATIONS FOR TREATMENT OF SCHIZOPHRENIA
2y 9m to grant Granted Sep 29, 2026
Patent 12741934
METHOD FOR THE PREPARATION OF DIARYLMETHANE DYES AND TRIARYLMETHANE DYES INCLUDING ISOSULFAN BLUE
4y 8m to grant Granted Sep 22, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
72%
Grant Probability
89%
With Interview (+16.5%)
3y 6m (~1y 1m remaining)
Median Time to Grant
Low
PTA Risk
Based on 83 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month